Novo Nordisk less likely to lift Wegovy sales guidance
London — Since launching its wildly well-liked weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual gross sales ...
London — Since launching its wildly well-liked weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual gross sales ...
London — Novo Holdings, the controlling shareholder of weight problems drugmaker Novo Nordisk, practically doubled annual revenue and funding returns ...